An investigation on behalf of investors in NASDAQ:CSII shares over possible wrongdoing by certain directors of Cardiovascular Systems Inc was announced
San Diego, CA -- (SBWIRE) -- 01/23/2018 -- An investigation was announced for investors in NASDAQ:CSII shares. The investigation by a law firm concerns whether certain directors of Cardiovascular Systems Inc potentially breached their fiduciary duties owed to NASDAQ:CSII stockholder.
Investors who are current long term investors in Cardiovascular Systems Inc (NASDAQ:CSII) shares, have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Cardiovascular Systems Inc directors breached their fiduciary duties and caused damage to the company and its shareholders.
In February 2016 a lawsuit was filed against Cardiovascular Systems Inc over alleged securities laws violations. The plaintiff alleged that the defendants issued allegedly false and misleading statements to investors and/or allegedly failed to disclose that Cardiovascular Systems distributed illegal kickbacks to health care providers, that Cardiovascular Systems engaged in the off-label promotion of its medical devices, and that Cardiovascular Systems violated FDA laws and regulations in connection with its medical devices.
In June 2016, Cardiovascular Systems Inc agreed to pay $8 million to resolve allegations by the Department of Justice that it paid illegal kickbacks to induce physicians to use the Company's medical devices.
Those who purchased shares of Cardiovascular Systems Inc (NASDAQ:CSII) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego